The Impact of Plasmakinetic Resection and Conventional Transurethral Resection of the Prostate on Clinical Symptoms and Quality of Life in Patients with Benign Prostatic Hyperplasia: Retrospective Cohort Study
Urology Journal,
Vol. 22 No. 02 (2025),
2 March 2025
,
Page 106-113
https://doi.org/10.22037/uj.v22i.8330
Abstract
Purpose: Benign prostatic hyperplasia (BPH) is a condition commonly observed in elderly males, leading to lower urinary tract symptoms and potential complications. Surgical procedures primarily include transurethral resection of the prostate (TURP) and plasmakinetic resection, with their effectiveness under active research and clinical interest.
Materials and Methods: This retrospective cohort study compared the impacts of plasmakinetic resection and conventional TURP on clinical symptoms and quality of life in patients with benign prostatic hyperplasia. It encompassed surgical duration, postoperative complications, urodynamic parameters, quality of life scores, sexual function, and long-term outcomes.
Results: Postoperative symptom improvements, including International Prostate Symptom Score (IPSS) and Quality of Life (QoL) score, were significantly higher in the plasmakinetic resection group (P = 0.033 and P = 0.003, respectively). Urodynamic parameters such as peak flow rate (P = 0.008), post-void residual volume (P = 0.044), and Qmax (P = 0.012) also showed significant improvements. Quality of life assessments, including (EuroQol-5 Dimensions)EQ-5D scores (P = 0.003), general health perception (P = 0.009), sexual function (P = 0.011), and overall satisfaction (P = 0.004) favored plasmakinetic resection. Plasmakinetic resection resulted in better outcomes for continence and sexual function. Long-term outcomes at 1 year post-operation, including IPSS scores (P = 0.006) and overall satisfaction (P = 0.002), were significantly better in the plasmakinetic resection group. No significant differences were observed in health care resource utilization.
Conclusion: The study suggests that plasmakinetic resection offers advantages over conventional TURP in symptom relief, quality of life, continence, sexual function, and long-term results for patients with BPH.
- Plasmakinetic Resection
- Conventional Transurethral Resection
- Clinical Symptoms
- Quality of Life
How to Cite
References
ElJalby M, Thomas D, Elterman D, Chughtai B. The effect of diet on BPH, LUTS and ED. World J Urol. 2019; 37:1001-5.
Kasraeian A, Alcantara M, Alcantara KM, Altamirando JA, Kasraeian A. Aquablation for BPH. Can J Urol. 2020; 27:10378-81.
Calogero AE, Burgio G, Condorelli RA, Cannarella R, La Vignera S. Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. Aging Male. 2019; 22:12-9.
Welén K, Damber JE. Androgens, aging, and prostate health. Rev Endocr Metab Disord. 2022;23(6):1221-1231.
Das K, Buchholz N. Benign prostate hyperplasia and nutrition. Clin Nutr ESPEN. 2019; 33:5-11.
Shvero A, Calio B, Humphreys MR, Das AK. HoLEP: the new gold standard for surgical treatment of benign prostatic hyperplasia. Can J Urol. 2021; 28:6-10.
Ene C, Geavlete P, Geavlete B. What's New in Bipolar TURP for Surgical Management of BPH? Chirurgia (Bucur). 2020; 115:307-13.
Yafi FA. Editorial Comment on: 1470 nm Diode Laser Enucleation vs Plasmakinetic Bipolar Resection of the Prostate for Benign Prostatic Hyperplasia: A Randomized Study by Zhang et al. (From: Zhang J, Wang X, Zhang Y, et al. J Endourol 2019;33:211-217; DOI: 10.1089/end.2018.0499). J Endourol. 2019; 33:218.
Habib EI, ElSheemy MS, Hossam A, Morsy S, Hussein HA, Abdelaziz AY, et al. Holmium Laser Enucleation Versus Bipolar Plasmakinetic Resection for Management of Lower Urinary Tract Symptoms in Patients with Large-Volume Benign Prostatic Hyperplasia: Randomized-Controlled Trial. J Endourol. 2021; 35:171-9.
Sinha MM, Pietropaolo A, Hameed BMZ, Gauhar V, Somani BK. Outcomes of bipolar TURP compared to monopolar TURP: A comprehensive literature review. Turk J Urol. 2022; 48:1-10.
Cheng X, Qin C, Xu P, Li Y, Peng M, Wu S, et al. Comparison of bipolar plasmakinetic resection of prostate versus photoselective vaporization of prostate by a three year retrospective observational study. Sci Rep. 2021; 11:10142.
Cicero AFG, Allkanjari O, Busetto GM, Cai T, Larganà G, Magri V, et al. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Arch Ital Urol Androl. 2019; 91:
Miernik A, Gratzke C. Current Treatment for Benign Prostatic Hyperplasia. Dtsch Arztebl Int. 2020; 117:843-54.
Plochocki A, King B. Medical Treatment of Benign Prostatic Hyperplasia. Urol Clin North Am. 2022; 49:231-8.
Bouhadana D, Nguyen DD, Zhang X, Mao J, Elterman DS, Te AE, et al. Safety and efficacy of TURP vs. laser prostatectomy for the treatment of benign prostatic hyperplasia in multi-morbid and elderly individuals aged ≥ 75. World J Urol. 2021; 39:4405-12.
Mostafa MM, Khallaf A, Khalil M, Elgammal MA, Mahdy A. Efficacy and safety of TURP, HoLEP, and PVP in the management of OAB symptoms complicating BPH in patients with moderately enlarged prostates: A comparative study. Can Urol Assoc J. 2023; 17:E1-e7.
Zhang J, Wang Y, Li S, Jin S, Zhang S, Zhao C, et al. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia. Urol Int. 2021; 105:735-42.
Zeng XT, Jin YH, Liu TZ, Chen FM, Ding DG, Fu M, et al. Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition). Mil Med Res. 2022; 9:14.
Alexander CE, Scullion MMF, Omar MI, Yuan Y, Mamoulakis C, N'Dow JMO, et al. Reprint - Bipolar vs. monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction: A Cochrane review. Can Urol Assoc J. 2020; 14:423-30.
Bruce A, Krishan A, Sadiq S, Ehsanullah SA, Khashaba S. Safety and Efficacy of Bipolar Transurethral Resection of the Prostate vs Monopolar Transurethral Resection of Prostate in the Treatment of Moderate-Large Volume Prostatic Hyperplasia: A Systematic Review and Meta-Analysis. J Endourol. 2021; 35:663-73.
Gomes CM, Moromizato JKM, Brandão TBV. Bipolar and monopolar transurethral resection of the prostate are equally effective and safe in this high quality randomized controled trial. Int Braz J Urol. 2021; 47:145-8.
Wu K, Jiang D, Zhang L, Jiang S, Lin T, Luo Y, et al. Efficacy and safety of a novel 450 nm blue diode laser versus plasmakinetic electrocautery for the transurethral resection of non-muscle invasive bladder cancer: The protocol and result of a multicenter randomized controlled trial. Front Oncol. 2022; 12:1065735.
Otaola-Arca H, Álvarez-Ardura M, Molina-Escudero R, Fernández MI, Páez-Borda Á. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications. Int Braz J Urol. 2021; 47:131-44.
Wang Z, Zhang J, Zhang H, Liu S, Sun D, Hu L, et al. Impact on sexual function of plasma button transurethral vapour enucleation versus plasmakinetic resection of the large prostate >90 ml: Results of a prospective, randomized trial. Andrologia. 2020; 52:e13390.
Jiang Y, Bai X, Zhang X, Wang M, Tian J, Mu L, et al. Comparative Study of the Effectiveness and Safety of Transurethral Bipolar Plasmakinetic Enucleation of the Prostate and Transurethral Bipolar Plasmakinetic Resection of the Prostate for Massive Benign Prostate Hyperplasia (>80 ml). Med Sci Monit. 2020; 26:e921272.
Chen C, Liu C, Xu P, Chen B, Xu A. Progressive pre-disconnection of urethral mucosal flap during transurethral plasmakinetic enucleation of prostate improves postoperative urinary continence. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52:156-61.
Zou Z, Zhang L, Cai K, Hu Y, Liu S, Chen J, et al. Feasibility and safety of bipolar-plasmakinetic transurethral enucleation and resection of the prostate in day surgery mode. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52:148-55.
Hsu FS, Chou CW, Chang HC, Tu YP, Sha SJ, Chung HH, et al. Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction. Sci Rep. 2019; 9:6427.
Hsu FS, Chou CW, Chang HC, Tu YP, Sha SJ, Chung HH, et al. Author Correction: Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction. Sci Rep. 2019; 9:17872.
Xiao KW, Zhou L, He Q, Chen G, Gao XS, Liu Y, et al. Transurethral endoscopic enucleation of the prostate using a diode laser versus bipolar plasmakinetic for benign prostatic obstruction: a meta-analysis. Lasers Med Sci. 2020; 35:1159-69.
- Abstract Viewed: 160 times
- 8330/pdf Downloaded: 73 times